Cargando…

A prospective study of adverse drug reactions to antiepileptic drugs in children

OBJECTIVES: To prospectively determine the nature and rate of adverse drug reactions (ADRs) in children on antiepileptic drugs (AEDs) and to prospectively evaluate the effect of AEDs on behaviour. SETTING: A single centre prospective observational study. PARTICIPANTS: Children (<18 years old) rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Mark, Egunsola, Oluwaseun, Cherrill, Janine, Millward, Claire, Fakis, Apostolos, Choonara, Imti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458612/
https://www.ncbi.nlm.nih.gov/pubmed/26033949
http://dx.doi.org/10.1136/bmjopen-2015-008298
_version_ 1782375108544823296
author Anderson, Mark
Egunsola, Oluwaseun
Cherrill, Janine
Millward, Claire
Fakis, Apostolos
Choonara, Imti
author_facet Anderson, Mark
Egunsola, Oluwaseun
Cherrill, Janine
Millward, Claire
Fakis, Apostolos
Choonara, Imti
author_sort Anderson, Mark
collection PubMed
description OBJECTIVES: To prospectively determine the nature and rate of adverse drug reactions (ADRs) in children on antiepileptic drugs (AEDs) and to prospectively evaluate the effect of AEDs on behaviour. SETTING: A single centre prospective observational study. PARTICIPANTS: Children (<18 years old) receiving one or more AEDs for epilepsy, at each clinically determined follow-up visit. PRIMARY AND SECONDARY OUTCOMES: Primary outcome was adverse reactions of AEDs. Behavioural and cognitive functions were secondary outcomes. RESULTS: 180 children were recruited. Sodium valproate and carbamazepine were the most frequently used AEDs. A total of 114 ADRs were recorded in 56 of these children (31%). 135 children (75%) were on monotherapy. 27 of the 45 children (60%) on polytherapy had ADRs; while 29 (21%) of those on monotherapy had ADRs. The risk of ADRs was significantly lower in patients receiving monotherapy than polytherapy (RR: 0.61, 95% CI 0.47 to 0.79, p<0.0001). Behavioural problems and somnolence were the most common ADRs. 23 children had to discontinue their AED due to an ADR. CONCLUSIONS: Behavioural problems and somnolence were the most common ADRs. Polytherapy significantly increases the likelihood of ADRs in children. TRAIL REGISTRATION NUMBER: EudraCT (2007-000565-37).
format Online
Article
Text
id pubmed-4458612
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-44586122015-06-10 A prospective study of adverse drug reactions to antiepileptic drugs in children Anderson, Mark Egunsola, Oluwaseun Cherrill, Janine Millward, Claire Fakis, Apostolos Choonara, Imti BMJ Open Pharmacology and Therapeutics OBJECTIVES: To prospectively determine the nature and rate of adverse drug reactions (ADRs) in children on antiepileptic drugs (AEDs) and to prospectively evaluate the effect of AEDs on behaviour. SETTING: A single centre prospective observational study. PARTICIPANTS: Children (<18 years old) receiving one or more AEDs for epilepsy, at each clinically determined follow-up visit. PRIMARY AND SECONDARY OUTCOMES: Primary outcome was adverse reactions of AEDs. Behavioural and cognitive functions were secondary outcomes. RESULTS: 180 children were recruited. Sodium valproate and carbamazepine were the most frequently used AEDs. A total of 114 ADRs were recorded in 56 of these children (31%). 135 children (75%) were on monotherapy. 27 of the 45 children (60%) on polytherapy had ADRs; while 29 (21%) of those on monotherapy had ADRs. The risk of ADRs was significantly lower in patients receiving monotherapy than polytherapy (RR: 0.61, 95% CI 0.47 to 0.79, p<0.0001). Behavioural problems and somnolence were the most common ADRs. 23 children had to discontinue their AED due to an ADR. CONCLUSIONS: Behavioural problems and somnolence were the most common ADRs. Polytherapy significantly increases the likelihood of ADRs in children. TRAIL REGISTRATION NUMBER: EudraCT (2007-000565-37). BMJ Publishing Group 2015-05-30 /pmc/articles/PMC4458612/ /pubmed/26033949 http://dx.doi.org/10.1136/bmjopen-2015-008298 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Pharmacology and Therapeutics
Anderson, Mark
Egunsola, Oluwaseun
Cherrill, Janine
Millward, Claire
Fakis, Apostolos
Choonara, Imti
A prospective study of adverse drug reactions to antiepileptic drugs in children
title A prospective study of adverse drug reactions to antiepileptic drugs in children
title_full A prospective study of adverse drug reactions to antiepileptic drugs in children
title_fullStr A prospective study of adverse drug reactions to antiepileptic drugs in children
title_full_unstemmed A prospective study of adverse drug reactions to antiepileptic drugs in children
title_short A prospective study of adverse drug reactions to antiepileptic drugs in children
title_sort prospective study of adverse drug reactions to antiepileptic drugs in children
topic Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458612/
https://www.ncbi.nlm.nih.gov/pubmed/26033949
http://dx.doi.org/10.1136/bmjopen-2015-008298
work_keys_str_mv AT andersonmark aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT egunsolaoluwaseun aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT cherrilljanine aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT millwardclaire aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT fakisapostolos aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT choonaraimti aprospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT andersonmark prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT egunsolaoluwaseun prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT cherrilljanine prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT millwardclaire prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT fakisapostolos prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren
AT choonaraimti prospectivestudyofadversedrugreactionstoantiepilepticdrugsinchildren